So-Young International Inc
SY3.360USD
+0.390+13.13%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
282.37MMarket Cap
LossP/E TTM
More Details of So-Young International Inc Company
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
So-Young International Inc Info
Ticker SymbolSY
Company nameSo-Young International Inc
IPO dateMay 02, 2019
CEOJin (Xing)
Number of employees1800
Security typeDepository Receipt
Fiscal year-endMay 02
Address2/F, East Tower, Poly Plaza, No. 66 Xiangbin Road, Chaoyang District
CityBEIJING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code100102
Phone861087902012
Websitehttps://www.soyoung.com/
Ticker SymbolSY
IPO dateMay 02, 2019
CEOJin (Xing)
Company Executives of So-Young International Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Xing Jin
Mr. Xing Jin
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Haipeng Zhang, M.D.
Dr. Haipeng Zhang, M.D.
Independent Director
Independent Director
--
--
Prof. Chao He
Prof. Chao He
Independent Director
Independent Director
--
--
Mr. Xiaodong Ying
Mr. Xiaodong Ying
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Nan Huang
Mr. Nan Huang
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Hui Zhao
Mr. Hui Zhao
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Ms. Nan Shen
Ms. Nan Shen
Independent Director
Independent Director
--
--
Ms. Mona Qiao
Ms. Mona Qiao
Investor Relations
Investor Relations
--
--
Ms. Bei Wang
Ms. Bei Wang
Chief Marketing Officer
Chief Marketing Officer
--
--
Ms. Gefei Li
Ms. Gefei Li
Chief Operating Officer
Chief Operating Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Xing Jin
Mr. Xing Jin
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Haipeng Zhang, M.D.
Dr. Haipeng Zhang, M.D.
Independent Director
Independent Director
--
--
Prof. Chao He
Prof. Chao He
Independent Director
Independent Director
--
--
Mr. Xiaodong Ying
Mr. Xiaodong Ying
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Nan Huang
Mr. Nan Huang
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Hui Zhao
Mr. Hui Zhao
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Information services and other
998.81M
79.40%
Sales of equipment and maintenance services
259.07M
20.60%
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
1.47B
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Information services and other
998.81M
79.40%
Sales of equipment and maintenance services
259.07M
20.60%
Shareholding Stats
Updated: Sun, Feb 1
Updated: Sun, Feb 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Matrix Partners China
9.62%
TB Alternative Assets Ltd.
3.65%
Morgan Stanley & Co. LLC
1.30%
Kadensa Capital Limited
1.22%
Areo Holdings Ltd
0.84%
Other
83.36%
Shareholders
Shareholders
Proportion
Matrix Partners China
9.62%
TB Alternative Assets Ltd.
3.65%
Morgan Stanley & Co. LLC
1.30%
Kadensa Capital Limited
1.22%
Areo Holdings Ltd
0.84%
Other
83.36%
Shareholder Types
Shareholders
Proportion
Venture Capital
9.62%
Investment Advisor
5.26%
Hedge Fund
3.24%
Research Firm
2.87%
Corporation
1.12%
Investment Advisor/Hedge Fund
0.41%
Pension Fund
0.02%
Other
77.45%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
60
18.01M
21.43%
-2.31M
2025Q3
50
16.48M
19.69%
+799.52K
2025Q2
56
5.46M
6.45%
+3.53M
2025Q1
56
39.98M
47.25%
+2.34M
2024Q4
57
35.00M
40.69%
-4.68M
2024Q3
62
35.08M
40.78%
-22.79M
2024Q2
68
35.66M
41.41%
-22.81M
2024Q1
74
35.91M
41.67%
-24.80M
2023Q4
80
36.94M
43.37%
-24.33M
2023Q3
100
42.94M
49.19%
-27.05M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Matrix Partners China
8.09M
9.62%
-4.18M
-34.07%
Sep 30, 2025
TB Alternative Assets Ltd.
3.07M
3.65%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
1.09M
1.3%
+1.08M
+7747.86%
Sep 30, 2025
Kadensa Capital Limited
1.02M
1.22%
+1.02M
--
Sep 30, 2025
Areo Holdings Ltd
709.77K
0.84%
--
--
Feb 28, 2025
Citi Investment Research (US)
675.12K
0.8%
+626.96K
+1301.89%
Sep 30, 2025
Renaissance Technologies LLC
562.53K
0.67%
-700.00
-0.12%
Sep 30, 2025
Barclays Bank PLC
497.63K
0.59%
-126.17K
-20.23%
Sep 30, 2025
HCEP Management Limited
490.70K
0.58%
+490.70K
--
Sep 30, 2025
Nomura Securities Co., Ltd.
326.87K
0.39%
+326.87K
--
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Golden Dragon China ETF
0.11%
SPDR S&P Emerging Markets Small Cap ETF
0.02%
Avantis Emerging Markets Small Cap Equity ETF
0.01%
SPDR S&P China ETF
0.01%
ActivePassive International Equity ETF
0%
Invesco Golden Dragon China ETF
Proportion0.11%
SPDR S&P Emerging Markets Small Cap ETF
Proportion0.02%
Avantis Emerging Markets Small Cap Equity ETF
Proportion0.01%
SPDR S&P China ETF
Proportion0.01%
ActivePassive International Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
